{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:29:15Z","timestamp":1779290955789,"version":"3.51.4"},"posted":{"date-parts":[[2024,12,13]]},"group-title":"Oncology","reference-count":79,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,13]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Supraphysiological androgen (SPA) treatment can paradoxically restrict growth of castration-resistant prostate cancer with high androgen receptor (AR) activity, which is the basis for use of Bipolar Androgen Therapy (BAT) for patients with this disease. While androgens are widely appreciated to enhance anabolic metabolism, how SPA-mediated metabolic changes alter prostate cancer progression and therapy response is unknown. Here, we report that SPA markedly increased intracellular and secreted polyamines in prostate cancer models. This occurred through AR binding at enhancer sites upstream of the\n                  <jats:italic>ODC1<\/jats:italic>\n                  promoter to increase abundance of ornithine decarboxylase (ODC), a rate-limiting enzyme of polyamine synthesis, and de novo synthesis of polyamines from arginine. SPA-stimulated polyamines enhance prostate cancer fitness, as dCas9-KRAB-mediated inhibition of AR regulation of\n                  <jats:italic>ODC1<\/jats:italic>\n                  or direct ODC inhibition by difluoromethylornithine (DFMO) increased efficacy of SPA. Mechanistically, this occurred in part due to increased activity of S-adenosylmethionine decarboxylase 1 (AMD1), which was stimulated both by AR and by loss of negative feedback by polyamines, leading to depletion of its substrate S-adenosylmethionine and global protein methylation. These data provided the rationale for a clinical trial testing the safety and efficacy of BAT in combination with DFMO for patients with metastatic castration-resistant prostate cancer. Pharmacodynamic studies of this drug combination in the first five patients on trial indicated that the drug combination resulted in effective polyamine depletion in plasma. Thus, the AR potently stimulates polyamine synthesis, which constitutes a vulnerability in prostate cancer treated with SPA that can be targeted therapeutically.\n                <\/jats:p>","DOI":"10.1101\/2024.12.12.24318845","type":"posted-content","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T14:40:56Z","timestamp":1734100856000},"source":"Crossref","is-referenced-by-count":2,"title":["Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer"],"prefix":"10.64898","author":[{"given":"Rajendra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Jonnatan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Sanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Vakkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoushka","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L","family":"Dalrymple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra E","family":"Holbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Nwafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srushti","family":"Kittane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Penner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petya","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi V","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eneda","family":"Toska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo M","family":"De Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika L","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy Murray","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Robert A","family":"Casero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel R","family":"Denmeade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A","family":"Sena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024121603051191000_2024.12.12.24318845v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp030"},{"key":"2024121603051191000_2024.12.12.24318845v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.158"},{"key":"2024121603051191000_2024.12.12.24318845v1.3","doi-asserted-by":"crossref","unstructured":"L. A. Sena , S. R. Denmeade , Fatty acid synthesis in prostate cancer: vulnerability or epiphenomenon? Cancer Res., canres.1392.2021 (2021).","DOI":"10.1158\/0008-5472.CAN-21-1392"},{"key":"2024121603051191000_2024.12.12.24318845v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.11.017"},{"key":"2024121603051191000_2024.12.12.24318845v1.5","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","year":"2023","journal-title":"J. Clin. Oncol"},{"key":"2024121603051191000_2024.12.12.24318845v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00686-y"},{"key":"2024121603051191000_2024.12.12.24318845v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22504"},{"key":"2024121603051191000_2024.12.12.24318845v1.8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162396"},{"key":"2024121603051191000_2024.12.12.24318845v1.9","doi-asserted-by":"crossref","unstructured":"S. R. Denmeade , H. Wang , N. Agarwal , D. C. Smith , M. T. Schweizer , M. N. Stein , V. Assikis , P. W. Twardowski , T. W. Flaig , R. Z. Szmulewitz , J. M. Holzbeierlein , R. J. Hauke , G. Sonpavde , J. A. Garcia , A. Hussain , O. Sartor , S. Mao , H. Cao , W. Fu , T. Wang , R. Abdallah , S. J. Lim , V. Bolejack , C. J. Paller , M. A. Carducci , M. C. Markowski , M. A. Eisenberger , E. S. Antonarakis , TRANSFORMER: A randomized phase II study comparing bipolar androgen therapy versus enzalutamide in asymptomatic men with castration-resistant metastatic prostate cancer. J. Clin. Oncol., JCO2002759 (2021).","DOI":"10.1200\/JCO.20.02759"},{"key":"2024121603051191000_2024.12.12.24318845v1.10","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0507"},{"key":"2024121603051191000_2024.12.12.24318845v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0050-3"},{"key":"2024121603051191000_2024.12.12.24318845v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01479-6"},{"key":"2024121603051191000_2024.12.12.24318845v1.13","doi-asserted-by":"publisher","DOI":"10.1042\/bj1090032Pa"},{"key":"2024121603051191000_2024.12.12.24318845v1.14","doi-asserted-by":"publisher","DOI":"10.1042\/bj1170017"},{"key":"2024121603051191000_2024.12.12.24318845v1.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1984.tb38277.x"},{"key":"2024121603051191000_2024.12.12.24318845v1.16","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1016\/S0021-9258(18)34316-3","article-title":"Androgenic regulation of ornithine decarboxylase activity in mouse kidney and its relationship to changes in cytosol and nuclear androgen receptor concentrations","volume":"257","year":"1982","journal-title":"J. Biol. Chem"},{"key":"2024121603051191000_2024.12.12.24318845v1.17","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1016\/S0021-9258(18)32281-6","article-title":"Ornithine decarboxylase in mouse kidney. Purification, characterization, and radioimmunological determination of the enzyme protein","volume":"258","year":"1983","journal-title":"J. Biol. Chem"},{"key":"2024121603051191000_2024.12.12.24318845v1.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902651116"},{"key":"2024121603051191000_2024.12.12.24318845v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.08.011"},{"key":"2024121603051191000_2024.12.12.24318845v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.022"},{"key":"2024121603051191000_2024.12.12.24318845v1.21","doi-asserted-by":"crossref","unstructured":"T. Mann , The biochemistry of semen (Methuen, London, 1954).","DOI":"10.5962\/bhl.title.6940"},{"key":"2024121603051191000_2024.12.12.24318845v1.22","first-page":"97","article-title":"Uber die quantitative bestimmung des spermins im organismus und sein vorkommen in menschlichen geweben und korperflussingkeiten","volume":"23","year":"1941","journal-title":"Acta Soc. Med"},{"key":"2024121603051191000_2024.12.12.24318845v1.23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","year":"2022","journal-title":"Nature"},{"key":"2024121603051191000_2024.12.12.24318845v1.24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R116.731661"},{"key":"2024121603051191000_2024.12.12.24318845v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(91)90196-C"},{"key":"2024121603051191000_2024.12.12.24318845v1.26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/j.1939-4640.1998.tb01981.x","article-title":"Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells","volume":"19","year":"1998","journal-title":"J. Androl"},{"key":"2024121603051191000_2024.12.12.24318845v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/nature13229"},{"key":"2024121603051191000_2024.12.12.24318845v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3419"},{"key":"2024121603051191000_2024.12.12.24318845v1.29","first-page":"879","article-title":"Hay, c-Myc induces the expression and activity of ornithine decarboxylase","volume":"4","year":"1993","journal-title":"Cell Growth Differ"},{"key":"2024121603051191000_2024.12.12.24318845v1.30","doi-asserted-by":"crossref","first-page":"27277","DOI":"10.1016\/S0021-9258(19)74246-X","article-title":"Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex","volume":"268","year":"1993","journal-title":"J. Biol. Chem"},{"key":"2024121603051191000_2024.12.12.24318845v1.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.16.7804"},{"key":"2024121603051191000_2024.12.12.24318845v1.32","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1038\/s41467-021-27077-y","article-title":"Androgen receptor and MYC equilibration centralizes on developmental super-enhancer","volume":"12","year":"2021","journal-title":"Nat. Commun"},{"key":"2024121603051191000_2024.12.12.24318845v1.33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2017.04.006","article-title":"C-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks","volume":"18","year":"2017","journal-title":"EBioMedicine"},{"key":"2024121603051191000_2024.12.12.24318845v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30257-z"},{"key":"2024121603051191000_2024.12.12.24318845v1.35","doi-asserted-by":"publisher","DOI":"10.1021\/ja00476a050"},{"key":"2024121603051191000_2024.12.12.24318845v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.111"},{"key":"2024121603051191000_2024.12.12.24318845v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.12.040"},{"key":"2024121603051191000_2024.12.12.24318845v1.38","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1016\/S0021-9258(18)67095-4","article-title":"Increased content of mRNA for a precursor of S-adenosylmethionine decarboxylase in rat prostate after treatment with 2-difluoromethylornithine","volume":"261","year":"1986","journal-title":"J. Biol. Chem"},{"key":"2024121603051191000_2024.12.12.24318845v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.10.001"},{"key":"2024121603051191000_2024.12.12.24318845v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32659-w"},{"key":"2024121603051191000_2024.12.12.24318845v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.1.57"},{"key":"2024121603051191000_2024.12.12.24318845v1.42","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0658"},{"key":"2024121603051191000_2024.12.12.24318845v1.43","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00039.2012"},{"key":"2024121603051191000_2024.12.12.24318845v1.44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aar2606"},{"key":"2024121603051191000_2024.12.12.24318845v1.45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4627"},{"key":"2024121603051191000_2024.12.12.24318845v1.46","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030778"},{"key":"2024121603051191000_2024.12.12.24318845v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209198"},{"key":"2024121603051191000_2024.12.12.24318845v1.48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature22964","article-title":"mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer","volume":"547","year":"2017","journal-title":"Nature"},{"key":"2024121603051191000_2024.12.12.24318845v1.49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.TM118.003336"},{"key":"2024121603051191000_2024.12.12.24318845v1.50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2472"},{"key":"2024121603051191000_2024.12.12.24318845v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2014.11.012"},{"key":"2024121603051191000_2024.12.12.24318845v1.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13950-4"},{"key":"2024121603051191000_2024.12.12.24318845v1.53","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473"},{"key":"2024121603051191000_2024.12.12.24318845v1.54","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0911453"},{"key":"2024121603051191000_2024.12.12.24318845v1.55","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2016.71"},{"key":"2024121603051191000_2024.12.12.24318845v1.56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614958114"},{"issue":"1686\u201398","key":"2024121603051191000_2024.12.12.24318845v1.57","first-page":"1698.e1","article-title":"Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"2024121603051191000_2024.12.12.24318845v1.58","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200014020-00012"},{"key":"2024121603051191000_2024.12.12.24318845v1.59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc8929"},{"key":"2024121603051191000_2024.12.12.24318845v1.60","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS18-3445"},{"key":"2024121603051191000_2024.12.12.24318845v1.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.06.007"},{"key":"2024121603051191000_2024.12.12.24318845v1.62","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2018-4303"},{"key":"2024121603051191000_2024.12.12.24318845v1.63","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-1116"},{"key":"2024121603051191000_2024.12.12.24318845v1.64","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44235"},{"key":"2024121603051191000_2024.12.12.24318845v1.65","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81289"},{"key":"2024121603051191000_2024.12.12.24318845v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.031"},{"key":"2024121603051191000_2024.12.12.24318845v1.67","first-page":"701","article-title":"Use of difluoromethylornithine (DFMO, eflornithine) for late-stage African trypanosomiasis","volume":"81","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"2024121603051191000_2024.12.12.24318845v1.68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4269\/ajtmh.1987.37.525","article-title":"Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in C\u00f4te d\u2019Ivoire","volume":"37","year":"1987","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"2024121603051191000_2024.12.12.24318845v1.69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1200\/JCO.1984.2.2.124","article-title":"Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis","volume":"2","year":"1984","journal-title":"J. Clin. Oncol"},{"key":"2024121603051191000_2024.12.12.24318845v1.70","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0090-4295(86)90154-8","article-title":"Phase I trial of \u03b1-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer","volume":"28","year":"1986","journal-title":"Urology"},{"key":"2024121603051191000_2024.12.12.24318845v1.71","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae253"},{"key":"2024121603051191000_2024.12.12.24318845v1.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(83)94025-9"},{"key":"2024121603051191000_2024.12.12.24318845v1.73","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0076-6879(83)94041-7","article-title":"S-adenosylmethionine decarboxylase (rat liver)","volume":"94","year":"1983","journal-title":"Methods Enzymol"},{"key":"2024121603051191000_2024.12.12.24318845v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)83621-X"},{"key":"2024121603051191000_2024.12.12.24318845v1.75","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw257"},{"key":"2024121603051191000_2024.12.12.24318845v1.76","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2024121603051191000_2024.12.12.24318845v1.77","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"2024121603051191000_2024.12.12.24318845v1.78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2024121603051191000_2024.12.12.24318845v1.79","doi-asserted-by":"publisher","DOI":"10.1101\/060012"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.12.12.24318845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:22:45Z","timestamp":1768508565000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.12.12.24318845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":79,"URL":"https:\/\/doi.org\/10.1101\/2024.12.12.24318845","relation":{},"subject":[],"published":{"date-parts":[[2024,12,13]]},"subtype":"preprint"}}